Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
S
012790
vs
K
KOSPI 200
Over the past 12 months, Sinil Pharmaceutical Co Ltd has underperformed KOSPI 200, delivering a return of +5% compared to KOSPI 200's +56% growth.
Stocks Performance
012790 vs KOSPI 200
Performance Gap
012790 vs KOSPI 200
Performance By Year
012790 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Sinil Pharmaceutical Co Ltd
Glance View
Sinil Pharmaceutical Co Ltd is a South Korean drugmaker that develops, manufactures, and sells prescription medicines and over-the-counter health products. Its business centers on making pharmaceutical products that doctors, hospitals, pharmacies, and other healthcare channels can prescribe or stock for patients. The company makes money by selling finished medicines and related products through medical and retail distribution channels. Its customers are mainly healthcare providers, pharmacies, and distributors that buy the products and pass them on to patients and consumers. Like many pharmaceutical companies, it depends on product approvals, manufacturing quality, and steady demand for established treatments. What makes Sinil Pharmaceutical’s business easy to understand is that it sits in the middle of the drug supply chain: it turns formulated medicines into packaged products and earns money when those products move through the healthcare system. It is not a platform business or a branded consumer company; it is a medicines manufacturer and seller whose value comes from producing reliable pharmaceutical products for everyday medical use.